We are live on ! Find out more
EUCRW

Eucrates Biomedical Acquisition Corp. Warrant
EUCRW

Delisted

EUCRW was delisted on the 26th of April, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in Eucrates Biomedical Acquisition Corp. Warrant in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 22 → 0 (-22)

100% less capital invested

Capital invested by funds: $731K → $0 (-$731K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 22

Holders
–
Holders Change
-22
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
22
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$676K
2
DM
Deerfield Management
New York
-$13.5K
3
CAC
Cowen and Company
New York
-$8.2K
4
6CM
683 Capital Management
New York
-$7.95K
5
ACM
Altium Capital Management
New York
-$4.82K
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
– -$13.5K -333,333 Closed
CAC
2
Cowen and Company
New York
– -$8.2K -202,371 Closed
6CM
3
683 Capital Management
New York
– -$7.95K -196,348 Closed
ACM
4
Altium Capital Management
New York
– -$4.82K -133,333 Closed
AI
5
Arena Investors
New York
– -$3.45K -94,516 Closed
EC
6
EcoR1 Capital
California
– -$676K -66,666 Closed
KCM
7
Kingdon Capital Management
New York
– -$2.2K -66,665 Closed
RCM
8
Rivernorth Capital Management
Florida
– -$1.76K -58,548 Closed
AA
9
AQR Arbitrage
Connecticut
– -$1.86K -45,832 Closed
KPF
10
K2 Principal Fund
Ontario, Canada
– -$1.14K -34,509 Closed
CIM
11
Cowen Investment Management
New York
– -$1.35K -33,333 Closed
RCM
12
Radcliffe Capital Management
Pennsylvania
– -$1.21K -33,333 Closed
CH
13
CVI Holdings
Delaware
– -$1.25K -30,854 Closed
Jane Street
14
Jane Street
New York
– -$970 -26,838 Closed
HIM
15
HGC Investment Management
Ontario, Canada
– -$2K -26,383 Closed
SIA
16
Schechter Investment Advisors
Michigan
– -$861 -26,087 Closed
SC
17
Sculptor Capital
New York
– -$935 -25,881 Closed
T. Rowe Price Associates
18
T. Rowe Price Associates
Maryland
– -$1K -22,697 Closed
Citadel Advisors
19
Citadel Advisors
Florida
– -$736 -18,173 Closed
CS
20
Clear Street
New York
– -$107 -2,637 Closed
Morgan Stanley
21
Morgan Stanley
New York
– -$43 -1,300 Closed
Bank of America
22
Bank of America
North Carolina
– -$7 -215 Closed

EUCRW Hedge Fund Activity: Q2 2023 in Review

0 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Eucrates Biomedical Acquisition Corp. Warrant (EUCRW) for Q2 2023, worth a combined $0 — down 100% from $731K a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of EUCRW and 0 opened new positions — a net loss of 22 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was EcoR1 Capital, exiting entirely with an estimated $676K sold.

  • 0 institutional investors held Eucrates Biomedical Acquisition Corp. Warrant (EUCRW) as of Q2 2023, down from 22 in Q1 2023.
  • Funds reported $0 of Eucrates Biomedical Acquisition Corp. Warrant stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Eucrates Biomedical Acquisition Corp. Warrant positions in Q2 2023 and 22 closed out, a net change of -22 holders.
  • The largest Eucrates Biomedical Acquisition Corp. Warrant seller in Q2 2023 was EcoR1 Capital, an estimated $676K sold.

Based on aggregated 13F filings for Q2 2023.